Publications and Abstracts

In addition to the published clinical studies listed below, additional peer-reviewed studies on BCL6 will be published as available. Please check back as we update these references often.

  • July 2026

    Comparative Outcomes Of New BCL6-Guided Treatment Strategies In Women With Unexplained Infertility: A Multicenter Retrospective Analysis Of 2,451 Patients

    Dan Angress, Chris Jackson. North American Proceedings in Gynecology and Obstetrics. July 2026

    Content poster PDF
    Go to Article

  • September 2025

    BCL6 as a Marker of Uterine Lining Inflammation: A Retrospective Analysis of Treatment and Outcomes in Canada’s Largest User

    S. Tregoning MD, FCOG (SA), FRCSC, S. Sonnenberg, LPN, REI, D. Angress. Canadian Fertility and Andrology Society 71st annual meeting. September 2025
    Go to Article

  • June 2024

    Inflammatory Changes after Medical Suppression of Suspected Endometriosis for Implantation Failure: Preliminary Results

    Bruce A. Lessey,* Allan Dong, Jeffrey L. Deaton, Dan Angress, Ricardo F. Savaris and Stephen J. Walker. Int. J. Mol. Sci. 2024, 25(13), 6852.
    Go to Article

  • June 2024

    Shared Experience Outcomes In 1,416 Women With Unexplained Infertility Tested With ReceptivaDx™ (BCL6): Effect of Treatment On Subsequent Embryo Transfer

    Dan Angress. MRSI Abstract, June 2024
    Go to Article

  • June 2024

    Letrozole as a Treatment Option Alternative to GNRH Agonists and Laparoscopy in BCL6 Positive Patients

    Aimee Eyvazzadeh, MD, MPH; Lucia Santistevan, MD; Dan Angress. MRSI Abstract, June 2024
    Go to Article

  • March 2024

    Unexplained Euploid Embryo Transfer Failure: Testing and Treatment Options

    Bruce A Lessey MD, PhD1, Allan Dong MD1, David Wininger PhD1, Jeffrey L Deaton MD1, Ricardo Savaris MD, PhD2. PCRS Abstract, March 2024
    Go to Article

  • January 2024

    The Prevalence of Endometriosis in Patients with Unexplained Infertility

    Camran Nezhat, Farrah Khoyloo, Angie Tsuei, Ellie Armani, Barbara Page, Thomas Rduch and Ceana Nezhat. J. Clin. Med. 2024, 13, 444.
    Go to Article

  • May 2022

    BCL6, a key oncogene, in the placenta, pre-eclampsia and endometriosis

    Frank Louwen, Nina-Naomi Kreis, Andreas Ritter, Alexandra Friemel, Christine Solbach, and Juping Yuan. Mol Cell 2003;12: 1551–1564.
    Go to Article

  • March 2022

    Retrospective analysis of the relative value of IVF failures on BCL6 results

    Dan Angress. PCRS Abstract March 2023
    Go to Article

  • March 2022

    Can We Accurately Diagnose Endometriosis without a Diagnostic Laparoscopy?

    Camran Nezhat, MD; Shruti Agarwal, DO. J Turk Ger Gynecol Assoc. 2022 Jun
    Go to Article

  • December 2021

    Reliability of 2D/3D transvaginal ultrasonographic (TVUS) features (MUSA) in diagnosing
    histological proven Adenomyosis using BCL6 biomarker in cases of reproductive failure

    Hosam Zaki FRCOG, Hani El Maghrabi MSc., Hosam El Attar,Mostafa El Khosht. Abstract Scientific Congress of Endometriosis and Uterine Disorders, Dec 2021
    Go to Article

  • December 2021

    “Gain Fading” A new reliable 3D transvaginal ultrasonographic(TVUS) feature helps in
    diagnosing histological proven Adenomyosis using BCL6 biomarker in cases of
    reproductive failure

    Hosam Zaki FRCOG, Hani El Maghrabi MSc., Hosam El Attar,Mostafa El Khosht. Abstract Scientific Congress of Endometriosis and Uterine Disorders, Dec 2021
    Go to Article
Find a Center
FREE Phone Consultation
Get Tested

Get Started

Get started and get answers. Find a center near you with our locator map. Questions? Call us for a free phone consultation. We’re here to help.